UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Applied DNA Sciences, Inc. |
(Name of Issuer) |
|
Common Stock |
(Title of Class of Securities) |
|
03815U201 |
(CUSIP Number) |
|
December 31, 2019
|
(Date of Event which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ☐ | Rule 13d-1(b) |
| ☒ | Rule 13d-1(c) |
| ☐ | Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 03815U201 | SCHEDULE 13G | Page 2 of 6
|
1 | NAME OF REPORTING PERSON OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Bruce Grossman | |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) ☐ (b) ☐ |
3 | SEC USE ONLY | |
4 | CITIZENSHIP OR PLACE OF ORGANIZATION USA | |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER 254,400 |
6 | SHARED VOTING POWER 100,000 |
7 | SOLE DISPOSITIVE POWER 254,400 |
8 | SHARED DISPOSITIVE POWER 100,000 |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 354,400 | |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ☐ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.9% | |
12 | TYPE OF REPORTING PERSON IN | |
The shares of Common Stock reported on this Schedule are indirectly beneficially owned by the Reporting Person.
Dillon Hill Capital, LLC, of which the Reporting Person is the sole member, directly owns: (i) $1,500,000 principal amount of secured convertible notes (the “Notes”) that are convertible into 69,444 shares of Common Stock of the Issuer, (ii) 185,000 shares of Common Stock of the Issuer and (iii) warrant to purchase up to 401,000 shares of Common stock of the Issuer (the “Warrants”).
Dillon Hill Investment Company LLC, the sole member of which is a trust of which the Reporting Person’s spouse is the co-trustee, directly owns 100,000 shares of Common Stock and 513,739 Warrants.
The Reporting Person may be deemed to have sole voting and dispositive power over shares, Notes and Warrants held by Dillon Hill Capital LLC and shared voting and dispositive power over the shares and Warrants held by Dillon Hill Investment Company LLC.
The Notes and the Warrants include a provision limiting conversion of the Notes and exercise of the Warrants to the extent that conversion or exercise would result in the Reporting Person beneficially owning more than 9.99% of the Issuer’s Common Stock. As a result, the conversion of the Notes and the exercise of the Warrants by the Reporting Person may be limited and the amounts shown in Items 5 through 9 of the cover page to this schedule reflect only the Common Stock held by the Reporting Person and the Common Stock issuable upon conversion of the Notes.
The percentage beneficial ownership reported in Item 11 of the cover pages to this Schedule was calculated based on 3,485,399 shares of Common Stock outstanding as of January 27, 2020, as reported in the Issuer’s quarterly report on Form 10-K/A for the period ended September 30, 2019.